Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Dexmedetomidine-esketamine combination
The First People's Hospital of Lianyungang
Liver Cancer
1 trial -
Dextrometropine and 0.9% sodium chloride solution
The First People's Hospital of Lianyungang
Cataract
1 trial -
Diagnostic Test: conventional imaging (CT, MRI or 18F-FDG PET/CT), DLL3-targeted PET/CT
The First People's Hospital of Lianyungang
DLL3-expressing Tumors
1 trial -
Dietary intervention + Physical Activity + Monitoring
NORTHWEST BIOTHERAPEUTICS INC
Gestational Diabetes
1 trial -
Drugs and Stimulation
The First People's Hospital of Lianyungang
Hearing Loss, Sudden
1 trial -
Dynamometric tension assessment
The First People's Hospital of Lianyungang
Incisional Hernia
1 trial -
EAA
United Therapeutics Europe Ltd
Military Operational Stress Reaction
1 trial -
ERA
NORTHWEST BIOTHERAPEUTICS INC
Infertility, Female
1 trial -
ESC 0/1 hour troponin pathway
NORTHWEST BIOTHERAPEUTICS INC
Acute Coronary Syndrome
1 trial -
ET-01
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Transfusion Dependent Beta-Thalassaemia
1 trial -
ET-01
Guangzhou Virotech Pharmaceutical Co.,
Transfusion Dependent Beta-Thalassaemia
1 trial -
EUS-guided portal vein and hepatic vein aspiration
Chinese University of Hong Kong
Circulating Tumor Cell
1 trial -
EVM18001 Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
System Lupus Erythematosus(SLE)
1 trial -
Early Nutrition Intervention
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Nutrition
1 trial -
Eefooton oral solution
Hospital Authority, Hong Kong
Chronic Kidney Diseases
1 trial -
Electroencephalography (EEG)/Magnetoencephalography (MEG)/MRI
BRIGHT MINDS BIOSCIENCES INC.
Chronic Pain
1 trial -
Energy Balance
United Therapeutics Europe Ltd
Inflammation
1 trial -
Enteral immunonutrition
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Locally Advanced Nasopharyngeal Carcinoma
1 trial -
Erythromycin 4% topical gel formulation:
BRIGHT MINDS BIOSCIENCES INC.
Inflammation; Skin
1 trial -
Escitalopram
BRIGHT MINDS BIOSCIENCES INC.
Depressive Disorder, Major
1 trial -
Escitalopram (Oral antidepressant)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Depression - Major Depressive Disorder
1 trial -
Esketamine
The First People's Hospital of Lianyungang
Post Induction Hypotension
1 trial -
Esketamine
The First People's Hospital of Lianyungang
Postoperative Cognitive Dysfunction
1 trial -
Esketamine nasal spray
United Therapeutics Europe Ltd
Depression
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources